Menopause treatments: evidence-graded options
By MenoVerdict editorial team · Not yet medically reviewed
General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.
Treatments for perimenopause and menopause fall into three primary categories: hormonal therapies, non-hormonal prescription medications, and behavioral or lifestyle strategies [@nams-2022-hormone-therapy, @nams-2023-nonhormone-therapy].
Selecting an approach depends on your most disruptive symptoms, personal medical history, individual risk factors, and personal preferences.
1. Menopausal Hormone Therapy (MHT / HRT)
Systemic hormone therapy (HRT) replaces declining estrogen and, for women with an intact uterus, adds a progestogen to protect the uterine lining:
- Efficacy: Strong clinical evidence proves systemic hormone therapy is the most effective approach for reducing hot flash frequency and severity, stopping night sweats, and preventing rapid bone mineral loss.
- Forms: Available as transdermal patches, topical gels, sprays, and oral tablets, plus low-dose local vaginal estrogen for genitourinary symptoms. Transdermal estrogen is associated with lower thromboembolic risks compared to oral formulations.
- Safety and modern labels: Read our detailed breakdown of recent regulatory updates in The FDA HRT boxed warning change, explained.
2. Non-hormonal prescription options
For women who have contraindications to hormones (such as estrogen-sensitive breast cancer or unexplained vaginal bleeding) or who choose not to use them, several non-hormonal treatments for hot flashes demonstrate proven efficacy:
- Neurokinin 3 (NK3) receptor antagonists: Specifically target KNDy neurons in the hypothalamus to restore normal temperature regulation without systemic hormone exposure, including Veozah (fezolinetant) and dual NK1/NK3 blocker Lynkuet (elinzanetant).
- Selective serotonin and norepinephrine reuptake inhibitors (SSRIs/SNRIs): Low-dose paroxetine, venlafaxine, or desvenlafaxine reduce vasomotor frequency in clinical trials.
- Gabapentinoids: Modestly reduce nocturnal hot flashes and promote continuous sleep.
3. Behavioral and non-drug options
Clinical guidelines highlight cognitive and behavioral methods as effective tools for symptom distress:
- Cognitive Behavioral Therapy for Insomnia (CBT-I): Strong evidence supports CBT-I for reducing sleep disruption and the emotional distress associated with hot flashes.
- Cooling strategies: Breathable bedding, personal fans, and layer adjustments provide situational comfort, although they do not alter internal hypothalamic thermoregulation.
Evaluating popular supplements
The market for over-the-counter menopause supplements is large, but trial results vary significantly from marketing claims. Review our independent assessments in the Does It Work? evidence directory.
Further reading on treatments and doctor discussions
For an extensive doctor-authored guide to perimenopause symptoms, communication strategies for doctor visits, and modern hormone therapy discussions, read our review of The New Menopause by Dr Mary Claire Haver. You can also build a customized appointment sheet with our treatment conversation builder, compare options in the evidence checker tool, and log your daily patterns using our on-device symptom diary and doctor summary.
Where are you right now?
Still tracking
Not sure if your symptoms fit? Start tracking your daily patterns.
Log and spot your patterns with the symptom checklist →Ready to talk to a doctor
Have an upcoming appointment? Bring structured questions and your history.
Prepare your 10-minute doctor appointment questions →Already on treatment
Evaluating your response or wondering what to adjust next?
Explore evidence-graded treatment and lifestyle options →In this section
Related pages
- The FDA HRT boxed warning change, explained →
- Menopause Books Worth Reading, Chosen by Evidence →
- Does it work? Menopause treatments tested against evidence →
- Menopause symptom tracker and doctor report →
- Best menopause telehealth: compared by situation →
- Does it work? Menopause treatment evidence checker →
References
- The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (The North American Menopause Society, now The Menopause Society), 2022. Funding: Funded by donations to the NAMS Education & Research Fund; the statement reports no commercial support. Individual panel disclosures not yet reviewed..
- Shufelt CL, Brown V, Carpenter JS et al.. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause (The North American Menopause Society, now The Menopause Society), 2023.
Change log
- : Initial publication of treatments hub